Abstract
43986 Effectiveness in real world practice after fifty-two weeks of Risankizumab treatment for patients with moderate-to-severe psoriasis: thirty-one patient cohort
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have